Travere Therapeutics
Develops and sells rare kidney-disease medicines led by FILSPARI.
$65.49
After-hours close−0.16 (−0.24%)
At close$65.65(−2.77%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | $0.03 | — | — |
| Aug 2026 | −$0.13 | −$0.37 | −174.8% |
| May 2026 | −$0.30 | −$0.39 | −30.0% |
| Feb 2026 | $0.03 | $0.03 | 0.0% |
| Oct 2025 | −$0.31 | $0.28 | +190.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Jul 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | $0.03 | — | — | $195.2M | — | — |
| Aug 4, 2026 | −$0.13 | −$0.37 | −174.8% | $157.3M | $169.6M | +7.8% |
| May 4, 2026 | −$0.30 | −$0.39 | −30.0% | $136.2M | $127.2M | −6.6% |
| Feb 19, 2026 | $0.03 | $0.03 | 0.0% | $144.6M | $129.7M | −10.3% |
| Oct 30, 2025 | −$0.31 | $0.28 | +190.3% | $147.0M | $164.9M | +12.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 6, 2025 | ||||||
| May 1, 2025 | ||||||
| Feb 20, 2025 | ||||||
| Oct 31, 2024 | ||||||
| Aug 1, 2024 | ||||||
| May 6, 2024 | ||||||
| Feb 15, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 3, 2023 | ||||||
| May 4, 2023 | ||||||
| Feb 23, 2023 | ||||||
| Oct 27, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 5, 2022 | ||||||
| Feb 24, 2022 | ||||||
| Oct 28, 2021 | ||||||
| Jul 29, 2021 | ||||||
| May 6, 2021 | ||||||
| Mar 1, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Jul 30, 2020 | ||||||
| May 11, 2020 | ||||||
| Feb 24, 2020 | ||||||
| Oct 30, 2019 | ||||||
| Aug 6, 2019 | ||||||
| May 7, 2019 | ||||||
| Feb 26, 2019 | ||||||
| Nov 1, 2018 | ||||||
| Jul 26, 2018 | ||||||
| May 1, 2018 | ||||||
| Feb 27, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 9, 2017 | ||||||
| May 4, 2017 | ||||||
| Mar 1, 2017 | ||||||
| Nov 3, 2016 | ||||||
| Aug 4, 2016 | ||||||
| May 3, 2016 | ||||||
| Feb 25, 2016 | ||||||
| Nov 3, 2015 | ||||||
| Aug 4, 2015 | ||||||